Rocket Pharmaceuticals (RCKT) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to $709000.0.
- Rocket Pharmaceuticals' Interest & Investment Income fell 4657.12% to $709000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 4446.68%. This contributed to the annual value of $8.3 million for FY2024, which is 5633.51% up from last year.
- According to the latest figures from Q3 2025, Rocket Pharmaceuticals' Interest & Investment Income is $709000.0, which was down 4657.12% from $483000.0 recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' Interest & Investment Income ranged from a high of $3.0 million in Q1 2024 and a low of $483000.0 during Q2 2025
- In the last 5 years, Rocket Pharmaceuticals' Interest & Investment Income had a median value of $911000.0 in 2021 and averaged $1.2 million.
- In the last 5 years, Rocket Pharmaceuticals' Interest & Investment Income soared by 25864.98% in 2021 and then plummeted by 7894.51% in 2025.
- Rocket Pharmaceuticals' Interest & Investment Income (Quarter) stood at $850000.0 in 2021, then skyrocketed by 46.47% to $1.2 million in 2022, then tumbled by 34.62% to $814000.0 in 2023, then skyrocketed by 98.65% to $1.6 million in 2024, then tumbled by 56.15% to $709000.0 in 2025.
- Its last three reported values are $709000.0 in Q3 2025, $483000.0 for Q2 2025, and $1.3 million during Q1 2025.